Kirkland Signature Aller Fex Allergy Tablets Recalled for Failed Impurities Specifications
L. Perrigo Company recalls Kirkland Signature Aller Fex allergy tablets nationwide due to certain lots failing impurities and degradation quality specifications. Consumers with affected lots should contact their healthcare provider.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses, injuries, or adverse events. The hazard—failed impurities and degradation specifications—represents a quality control issue without demonstrated patient harm, consistent with a precautionary recall classification.
Plain-English summary
L. Perrigo Company is recalling Kirkland Signature Aller Fex (Fexofenadine Hydrochloride) 180 mg tablets because specific batches failed to meet FDA impurities and degradation specifications. The affected product includes 180-count cartons distributed nationwide.
Approximately 360,184 units have been distributed throughout the United States. Consumers should check their tablets against the affected lot numbers provided in the recall notice, which include lots with expiration dates ranging from November 2023 through April 2024.
If you have used this product, consult your healthcare provider if you have any concerns. Do not use affected lot numbers. Return the medication to your pharmacy or follow FDA disposal guidance.
The recalled product
- Product
- KIRKLAND SIGNATURE ALLER FEX (FEXOFENADINE HYDROCHLORIDE)
- Brand
- KIRKLAND SIGNATURE ALLER FEX
- Manufacturer
- L. Perrigo Company
- Category
- Drug — OTC Antihistamine
- Hazard
- chemical-degradation
- impurity
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: 2DV1487
- 2DV1870
- 2DV1871
- 2DV1873
- 2EV1676
- 2GV2132
- 2HV2679
- Exp. date 12/23
- 2DV2000
- exp. date 11/23
- 2LV1573
- 2MV1314
- Exp. date 04/24
- 2FV1764
- 2FV1765 2FV1766
- 2GV1579
- 2GV1937
- 2GV1941
- 2GV1942
- 2GV2157
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27